263 related articles for article (PubMed ID: 21962913)
21. Neuregulin-1 enhances depolarization-induced GABA release.
Woo RS; Li XM; Tao Y; Carpenter-Hyland E; Huang YZ; Weber J; Neiswender H; Dong XP; Wu J; Gassmann M; Lai C; Xiong WC; Gao TM; Mei L
Neuron; 2007 May; 54(4):599-610. PubMed ID: 17521572
[TBL] [Abstract][Full Text] [Related]
22. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
23. Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine.
Lindahl JS; Keifer J
Neuropsychopharmacology; 2004 Nov; 29(11):2065-73. PubMed ID: 15138442
[TBL] [Abstract][Full Text] [Related]
24. Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model.
Li C; Tang Y; Yang J; Zhang X; Liu Y; Tang A
Neurochem Res; 2016 Aug; 41(8):2049-64. PubMed ID: 27097547
[TBL] [Abstract][Full Text] [Related]
25. Phencyclidine treatment increases NR2A and NR2B N-methyl-D-aspartate receptor subunit expression in rats.
Owczarek S; Hou J; Secher T; Kristiansen LV
Neuroreport; 2011 Dec; 22(17):935-8. PubMed ID: 22015741
[TBL] [Abstract][Full Text] [Related]
26. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
Baier PC; Blume A; Koch J; Marx A; Fritzer G; Aldenhoff JB; Schiffelholz T
Behav Brain Res; 2009 Dec; 205(1):96-101. PubMed ID: 19539658
[TBL] [Abstract][Full Text] [Related]
27. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons.
Wang C; Anastasio N; Popov V; Leday A; Johnson KM
Neuroscience; 2004; 125(2):473-83. PubMed ID: 15062989
[TBL] [Abstract][Full Text] [Related]
28. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
29. Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
Radonjić NV; Knezević ID; Vilimanovich U; Kravić-Stevović T; Marina LV; Nikolić T; Todorović V; Bumbasirević V; Petronijević ND
Neuropharmacology; 2010; 58(4-5):739-45. PubMed ID: 20036264
[TBL] [Abstract][Full Text] [Related]
30. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
Mouri A; Noda Y; Enomoto T; Nabeshima T
Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
[TBL] [Abstract][Full Text] [Related]
31. Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice.
Engel M; Snikeris P; Jenner A; Karl T; Huang XF; Frank E
Int J Neuropsychopharmacol; 2015 May; 18(7):pyu114. PubMed ID: 26478928
[TBL] [Abstract][Full Text] [Related]
32. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.
Bennett M
Aust N Z J Psychiatry; 2009 Aug; 43(8):711-21. PubMed ID: 19629792
[TBL] [Abstract][Full Text] [Related]
33. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
34. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
[TBL] [Abstract][Full Text] [Related]
35. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit.
Hanania T; Hillman GR; Johnson KM
Synapse; 1999 Mar; 31(3):229-39. PubMed ID: 10029241
[TBL] [Abstract][Full Text] [Related]
36. Perinatal asphyxia alters neuregulin-1 and COMT gene expression in the medial prefrontal cortex in rats.
Wakuda T; Iwata K; Iwata Y; Anitha A; Takahashi T; Yamada K; Vasu MM; Matsuzaki H; Suzuki K; Mori N
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():149-54. PubMed ID: 25194460
[TBL] [Abstract][Full Text] [Related]
37. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
38. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells.
Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF
Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729
[TBL] [Abstract][Full Text] [Related]
39. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
[TBL] [Abstract][Full Text] [Related]
40. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
